An invertebrate model to evaluate virulence in Aspergillus fumigatus: The role of azole resistance

Medical Mycology

Volumn 52, Issue 3, 2014, Pages 311-319

  Gomez Lopez, A ^a   Forastiero, A ^a   Cendejas Bueno, E ^a   Gregson, L ^b   Mellado, E ^a   Howard, S J ^b   Livermore, J L ^b   Hope, W W ^b   Cuenca Estrella, M ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

cyp51A gene; isogenic mutants; Nonmammalian model

Indexed keywords

ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ARTICLE; ASPERGILLUS FUMIGATUS; BLOOD CELL; CELL DENSITY; CONTROLLED STUDY; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS GROWTH; GALLERIA MELLONELLA; GENE MUTATION; IN VITRO STUDY; NONHUMAN;

CYP51A GENE; ISOGENIC MUTANTS; NONMAMMALIAN MODEL;

ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; AZOLES; CYTOCHROME P-450 ENZYME SYSTEM; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, FUNGAL; FUNGAL PROTEINS; HUMANS; LARVA; LEPIDOPTERA; VIRULENCE;

ASPERGILLUS FUMIGATUS; INVERTEBRATA;

EID: 84898910571     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1093/mmy/myt022     Document Type: Article

References (30)

1. Anderson JB. Evolution of antifungal-drug resistance: Mechanisms and pathogen fitness. Nat Rev Microbiol 2005; 3: 547-556.
2. Chen J, Li H, Li R, Bu D,Wan Z. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. J Antimicrob Chemother 2005; 55: 31-37.
3. Diaz-Guerra TM, Mellado E, Cuenca-Estrella M, Rodriguez-Tudela JL. A point mutation in the 14alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 2003; 47: 1120-1124.
4. Mellado E, Garcia-Effron G, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL. Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob Agents Chemother 2004; 48: 2747-2750.
5. Mellado E, Garcia-Effron G, Buitrago MJ et al. Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility. Antimicrob Agents Chemother 2005; 49: 2536-2538.
6. Mellado E, Garcia-Effron G, Alcazar-Fuoli L et al. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother 2007; 51: 1897-1904.
7. Verweij PE,Mellado E, MelchersWJ. Multiple-triazole-resistant aspergillosis. N Engl J Med 2007; 356: 1481-1483.
8. Howard SJ, Cerar D, Anderson MJ et al. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 2009; 15: 1068-1076.
9. Arendrup MC, Mavridou E, Mortensen KL et al. Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence. PLoS One 2010; 5: E10080.
10. Clemons KV, Stevens DA. The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence. Med Mycol 2005; 43 (Suppl 1): S101-S110.
11. Kavanagh K, Reeves EP. Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens. FEMS Microbiol Rev 2004; 28: 101-112.
12. Salzet M. Vertebrate innate immunity resembles a mosaic of invertebrate immune responses. Trends Immunol 2001; 22: 285-288.
13. Brennan M, Thomas DY, Whiteway M, Kavanagh K. Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae. FEMS Immunol Med Microbiol 2002; 34: 153-157.
14. Mylonakis E, Aballay A.Worms and flies as genetically tractable animal models to study host-pathogen interactions. Infect Immun 2005; 73: 3833-3841.
15. Mylonakis E. Galleria mellonella and the study of fungal pathogenesis: Making the case for another genetically tractable model host. Mycopathologia 2008; 165: 1-3.
16. Reeves EP, Messina CG, Doyle S, Kavanagh K. Correlation between gliotoxin production and virulence of Aspergillus fumigatus in Galleria mellonella. Mycopathologia 2004; 158: 73-79.
17. Renwick J, Daly P, Reeves EP, Kavanagh K. Susceptibility of larvae of Galleria mellonella to infection by Aspergillus fumigatus is dependent upon stage of conidial germination. Mycopathologia 2006; 161: 377-384.
18. Rodriguez-Tudela JL, Arendrup MC, Arikan S et al. EUCAST Definitive Document E.DEF 9.1: Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds. 2008. Available at http://www.eucast.org/antifungal-susceptibility-testing-afst.
19. Meletiadis J, te Dorsthorst DT, Verweij PE. Use of turbidimetric growth curves for early determination of antifungal drug resistance of filamentous fungi. J Clin Microbiol 2003; 41: 4718-4725.
20. Bowyer P, Moore CB, Rautemaa R, Denning DW, Richardson MD. Azole antifungal resistance today: Focus on Aspergillus. Curr Infect Dis Rep 2011; 13: 485-491.
21. Mortensen KL, Mellado E, Lass-Florl C et al. Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain. Antimicrob Agents Chemother 2010; 54: 4545-4549.
22. Mavridou E, Bruggemann RJ, Melchers WJ, Mouton JW, Verweij PE. Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene. Antimicrob Agents Chemother 2010; 54: 860-865.
23. Slater JL, Gregson L, Denning DW, Warn PA. Pathogenicity of Aspergillus fumigatus mutants assessed in Galleria mellonella matches that in mice. Med Mycol 2011; 49 (Suppl 1): S107-S113.
24. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A 1998; 95: 588-593.
25. Wittwer D, Franchini A, Ottaviani E,Wiesner A. Presence of IL-1-and TNF-like molecules in Galleria mellonella (Lepidoptera) haemocytes and in an insect cell line Fromestigmene acraea (Lepidoptera). Cytokine 1999; 11: 637-642.
26. Garcia-Rodas R, Casadevall A, Rodriguez-Tudela JL, Cuenca-Estrella M, Zaragoza O. Cryptococcus neoformans capsular enlargement and cellular gigantism during Galleria mellonella infection. PLoS One 2011; 6: E24485.
27. Garcia-Solache MA, Izquierdo-Garcia D, Smith C, Bergman A, Casadevall A. Fungal virulence in a lepidopteran model is an emergent property with deterministic features. MBio 2013; 4: E00100-e00113.
28. Mesa-Arango AC, Forastiero A, Bernal-Martinez L et al. The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast. Med Mycol 2013; 51: 461-472.
29. Ratcliffe NA. Invertebrate immunity-A primer for the nonspecialist. Immunol Lett 1985; 10: 253-270.
30. Bergin D, Brennan M, Kavanagh K. Fluctuations in haemocyte density and microbial load may be used as indicators of fungal pathogenicity in larvae of Galleria mellonella. Microbes Infect 2003; 5: 1389-1395.